OA10812A - High-content famciclovir tablets - Google Patents

High-content famciclovir tablets Download PDF

Info

Publication number
OA10812A
OA10812A OA9800116A OA9800116A OA10812A OA 10812 A OA10812 A OA 10812A OA 9800116 A OA9800116 A OA 9800116A OA 9800116 A OA9800116 A OA 9800116A OA 10812 A OA10812 A OA 10812A
Authority
OA
OAPI
Prior art keywords
famciclovir
tablet
tablets
lactose
pharmaceutical
Prior art date
Application number
OA9800116A
Other languages
English (en)
Inventor
Michael John Greenway
Jennifer Mary Slater
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA10812A publication Critical patent/OA10812A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
OA9800116A 1996-01-16 1998-07-16 High-content famciclovir tablets OA10812A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
OA10812A true OA10812A (en) 2003-01-29

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800116A OA10812A (en) 1996-01-16 1998-07-16 High-content famciclovir tablets

Country Status (37)

Country Link
US (1) US6765007B1 (fr)
EP (1) EP0874632B1 (fr)
JP (2) JP4711360B2 (fr)
KR (1) KR100338829B1 (fr)
CN (1) CN1132582C (fr)
AP (2) AP747A (fr)
AR (1) AR005456A1 (fr)
AT (1) ATE220910T1 (fr)
AU (1) AU713090B2 (fr)
BG (1) BG63488B1 (fr)
BR (1) BR9706982A (fr)
CY (1) CY2390B1 (fr)
CZ (1) CZ287205B6 (fr)
DE (1) DE69714215T2 (fr)
DK (1) DK0874632T3 (fr)
DZ (1) DZ2159A1 (fr)
EA (1) EA001946B1 (fr)
EG (1) EG23684A (fr)
ES (1) ES2180922T3 (fr)
GB (1) GB9600847D0 (fr)
HU (1) HU225472B1 (fr)
IL (1) IL124913A0 (fr)
MX (1) MX9805713A (fr)
MY (1) MY127527A (fr)
NO (1) NO315689B1 (fr)
NZ (1) NZ326769A (fr)
OA (1) OA10812A (fr)
PE (1) PE35498A1 (fr)
PL (1) PL187291B1 (fr)
PT (1) PT874632E (fr)
SK (1) SK282132B6 (fr)
TR (1) TR199800954T2 (fr)
TW (1) TW434016B (fr)
UA (1) UA63897C2 (fr)
UY (2) UY24437A1 (fr)
WO (1) WO1997025990A1 (fr)
ZA (1) ZA97310B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037790A2 (fr) * 2005-06-08 2007-04-05 Elan Corporation, Plc Compositions famciclovir à libération modifiée
ES2401008T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Comprimidos farmacéuticos sólidos para dispositivos implantables para la administración de fármacos
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
EP0182024B1 (fr) * 1984-09-20 1991-04-03 Beecham Group Plc Dérivés de purine et leur utilisation pharmaceutique
AU653203B2 (en) * 1991-01-30 1994-09-22 Wellcome Foundation Limited, The Water-dispersible tablets
KR100245252B1 (ko) 1991-05-15 2000-03-02 도로시 케이. 로빈슨 간에 의해 대사될 수 있는 프로드럭의 결정 및 그의 치료학적 용도
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
PL187291B1 (pl) 2004-06-30
CN1132582C (zh) 2003-12-31
IL124913A0 (en) 1999-01-26
EP0874632B1 (fr) 2002-07-24
EG23684A (en) 2007-05-09
PT874632E (pt) 2002-10-31
HUP9901021A3 (en) 2000-08-28
UA63897C2 (en) 2004-02-16
EP0874632A1 (fr) 1998-11-04
DE69714215D1 (de) 2002-08-29
UY24437A1 (es) 1997-06-06
AP1114A (en) 2002-10-18
BG102638A (bg) 1999-07-30
PE35498A1 (es) 1998-08-07
KR100338829B1 (ko) 2002-07-18
HUP9901021A2 (hu) 1999-08-30
AU713090B2 (en) 1999-11-25
CZ287205B6 (en) 2000-10-11
ZA97310B (en) 1997-10-23
EA001946B1 (ru) 2001-10-22
MY127527A (en) 2006-12-29
BR9706982A (pt) 1999-07-20
AP9700911A0 (en) 1997-01-31
NO983259L (no) 1998-07-15
JP2009091362A (ja) 2009-04-30
US6765007B1 (en) 2004-07-20
JP4711360B2 (ja) 2011-06-29
TW434016B (en) 2001-05-16
TR199800954T2 (xx) 1998-10-21
HU225472B1 (en) 2006-12-28
KR19990077229A (ko) 1999-10-25
MX9805713A (es) 1998-10-31
AR005456A1 (es) 1999-06-23
NZ326769A (en) 2000-05-26
GB9600847D0 (en) 1996-03-20
EA199800573A1 (ru) 1999-02-25
CY2390B1 (en) 2004-09-10
AU1541897A (en) 1997-08-11
WO1997025990A1 (fr) 1997-07-24
CN1208350A (zh) 1999-02-17
PL327922A1 (en) 1999-01-04
AP747A (en) 1999-05-03
AP9801298A0 (en) 1998-09-30
BG63488B1 (bg) 2002-03-29
DZ2159A1 (fr) 2002-12-01
JP2000503311A (ja) 2000-03-21
SK95698A3 (en) 1999-01-11
DE69714215T2 (de) 2003-01-23
NO315689B1 (no) 2003-10-13
NO983259D0 (no) 1998-07-15
DK0874632T3 (da) 2002-11-11
CZ225498A3 (cs) 1998-12-16
ATE220910T1 (de) 2002-08-15
HK1016473A1 (en) 1999-11-05
UY24556A1 (es) 2001-08-27
SK282132B6 (sk) 2001-11-06
ES2180922T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
AU653203B2 (en) Water-dispersible tablets
RU2155044C2 (ru) Фармацевтическая композиция, способ введения гепирона, оральная лекарственная форма
Bolhuis et al. Evaluation of anhydrous α-lactose, a new excipient in direct compression
WO1999033456A1 (fr) Compositions pharmaceutiques contenant du chlorhydrate de bupropione et un acide inorganique stabilisant
US5087454A (en) Ibuprofen tablet
CA2330391A1 (fr) Compositions pharmaceutiques homogenes comportant de l'abacavir, de la lamiduvine et de la zidovudine
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
JP2009091362A (ja) 高含量ファムシクロビル錠剤
US20060147519A1 (en) Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
CA1339194C (fr) Melange d'alginates et de polyacrylates; son utilisation
GB2067900A (en) Tablets containing trimethoprim, sulphamethoxazole and polyvinylpyrrolidone
CA2240462C (fr) Comprimes a forte teneur en famciclovir
HK1016473B (en) High-content famciclovir tablets
US20050163868A1 (en) Tablet composition containing chinese orthodox medicine extract and process for producing the same
JP2000229855A (ja) プラバスタチンナトリウム錠
JP4710240B2 (ja) 医薬組成物
RU2145218C1 (ru) Фармацевтическая композиция, обладающая противовирусным действием
MXPA00001517A (en) Compressed nitroglycerin tablet and its method of manufacture